Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery

Cardiovascular Research

Volumn 82, Issue 2, 2009, Pages 324-332

  Choi, Soo Kyoung ^a   Ahn, Duck Sun ^a   Lee, Young Ho ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Ca2+ i; Rabbit coronary artery; RhoA RhoA associated kinase; Sphingosine 1 phosphate; Sphingosylphosphorylcholine

Indexed keywords

BETA ESCIN; CALCIUM; CONTRACTILE PROTEIN; CYCLOPIAZONIC ACID; FASUDIL; MYOSIN LIGHT CHAIN PHOSPHATASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSYLPHOSPHORYLCHOLINE; THREONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; ENZYME PHOSPHORYLATION; EXTRACELLULAR CALCIUM; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; RABBIT;

ANIMALS; CALCIUM; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INDOLES; LYSOPHOSPHOLIPIDS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; PHOSPHORYLCHOLINE; RABBITS; RHO-ASSOCIATED KINASES; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 67449124301     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp054     Document Type: Article

References (40)

1. Hannun YA, Luberto C, Argraves KM. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 2001; 40: 4893-4903.
2. Kolesnick R. The therapeutic potential of modulating the ceramide/ sphingomyelin pathway. J Clin Invest 2001; 110: 3-8.
3. Okajima F. Plasma lipoproteins behave as carriers of extracellular sphingosine-1-phosphate: is this an atherogenic mediator or an antiatherogenic mediator? Biochim Biophys Acta 2002; 1582: 132-137.
4. Liliom K, Sun G, Bunemann M, Virag T, Nusser N, Baker DL et al. Sphingosylphosphorylcholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem J 2001; 355: 189-197.
5. Duong CQ, Bared SM, Abu-Khader A, Buechler C, Schmitz A, Schmitz G. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated response in human macrophages. Biochim Biophys Acta 2004; 1682: 112-119.
6. Bailou LR. Sphingolipids and cell function. Immunol Today 1992; 13: 339-341.
7. Kolesnick R. Signal transduction through the sphingomyelin pathway. Mol Chem Neuropathol 1994; 21: 287-297.
8. Alewijnse AE, Peters SL, Michel MC. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. Br J Pharmacol 2004; 143: 666-684.
9. Meyer zu Heringdorf D, Himmel HM, Jakobs KH. Sphingosylphosphorylcholine- biological functions and mechanisms of action. Biochim Biophys Acta 2002; 1582: 178-189.
10. Michel MC, Mulders AC, Jongsma M, Alewijnse AE, Peters SL. Vascular effects of sphingolipids. Acta Paediatrica 2007; 96: 44-48.
11. Peters SL, Alewijnse AE. Sphingosine-1-phosphate signaling in the cardiovascular system. Curr Opin Pharmacol 2007; 7: 186-192.
12. Hemmings DG, Xu Y, Davidge ST. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br J Pharmacol 2004; 143: 276-284.
13. 2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat. Naunyn-Schmideber's Arch Pharmacol 2006; 373: 30-36.
14. 3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 2003; 469: 125-134.
15. 2+ sensitization of vascular smooth muscle contraction: possible involvement of Rhokinase. FEBS Lett 2000; 482: 85-90.
16. Coussin F, Scott RH, Wise A, Nixon GF. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ Res 2002; 91: 151-157.
17. 3. J Clin Invest 2004; 113: 569-581.
18. Dantas AP, Igarashi J, Michel T. Sphingosine 1-phosphate and control of vascular tone. Am J Physiol Heart Circ Physiol 2003; 284: H2045-H2052.
19. 2+ elevation in endothelial cells in situ and causes endothelium dependent relaxation through nitric oxide production in bovine coronary artery. FEBS Lett 1999; 457: 375-380.
20. Bischoff A, Finger J, Michel MC. Nifedipine inhibits sphingosine- 1phosphate induced renovascular contraction in vitro and in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 2001; 364: 179-182.
21. 2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C. Circ Res 2002; 91: 112-119.
22. Bolz SS, Vogel L, Sollinger D, Derwand R, Boer C, Pitson SM et al. Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation 2003; 108: 342-347.
23. Hemmings DG, Hudson NK, Halliday D, O'Hara M, Baker PN, Davidge ST et al. Sphingosine-1-phosphate acts via Rho-associated kinase and nitric oxide to regulate human placental vascular tone. Biol Reprod 2006; 74: 88-94.
24. Weir B. The pathophysiology of cerebral vasospasm. Br J Neurosurg 1995; 9: 375-390.
25. Cook DA. The pharmacology of cerebral vasospasm. Pharmacology 1984; 29: 1-16.
26. Konodala S, Gutterman DD. Coronary vasospasm and the regulation of coronary blood flow. Prog Cardiovas Disease 2004; 46: 349-373.
27. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, Watanabe T et al. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 2001; 32: 2913-2319.
28. Dietrich HH, Dacey RG. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 2000; 46: 517-530.
29. Kalsner S. Coronary artery spasm. Multiple causes and multiple roles in heart disease. Biochem Pharmacol 1995; 49: 859-871.
30. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Eto Y, Morishige K et al. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm. Arterioscler Thromb Vasc Biol 2003; 23: 2209-2214.
31. Laher I, Zhang JH. Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metabol 2001; 21: 887-906.
32. Cho YE, Ahn DS, Kim YH, Taggart MJ, Lee YH. Changes in stretch-induced tone induced by intracellular acidosis in rabbit basilar artery: effects on BKca channel activity. Vasc Pharmacol 2007; 47: 74-82.
33. Ahn DS, Choi SK, Kim YH, Cho YE, Shin HM, Morgan KG et al. Enhanced stretch-induced myogenic tone in the basilar artery of spontaneously hypertensive rats. J Vasc Res 2007; 44: 182-191.
34. 2+ entry. Cardiovasc Res 2005; 68: 56-64.
35. Altmann C, Steenpaß V, Czyborra P, Hein P, Michel MC. Comparison of signaling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine. Br J Pharmacol 2003; 138: 261-271.
36. Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdore D, Jakobs KH, Michel MC. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 2000; 130: 1871-1877.
37. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rhokinase). Science 1996; 273: 245-248.
38. Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 2004; 259: 197-209.
39. Hartshorne DJ, Ito M, Erdodi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 1998; 19: 325-341.
40. Hla T, Lee MJ, Ancellin N, Liu CH, Thangada S, Thopson BD et al. Sphingosine-1-phosphate: extracellular mediators or intracellular second smessenger? Biochim Pharmacol 1999; 58: 201-207.